Trial intelligence / Profile preview

Phase 2 study of dacomitinib in cancer (Japan)

jRCT2080220960Phase 2Completed

Start

Jan 2010

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules